We provide you with 20 years of free, institutional-grade data for SRRK stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of SRRK. Explore the full financial landscape of SRRK stock.
| Reported Date | CIK | Ticker | Type | |
|---|---|---|---|---|
| 2025-08-06 | 1727196 | SRRK | 10-Q | Url |
| 2025-05-14 | 1727196 | SRRK | 10-Q | Url |
| 2025-02-27 | 1727196 | SRRK | 10-K | Url |
| 2024-11-12 | 1727196 | SRRK | 10-Q | Url |
| 2024-08-08 | 1727196 | SRRK | 10-Q | Url |
| 2024-05-07 | 1727196 | SRRK | 10-Q | Url |
| 2024-03-19 | 1727196 | SRRK | 10-K | Url |
| 2023-11-07 | 1727196 | SRRK | 10-Q | Url |
| 2023-08-09 | 1727196 | SRRK | 10-Q | Url |
| 2023-05-09 | 1727196 | SRRK | 10-Q | Url |
| 2023-03-07 | 1727196 | SRRK | 10-K | Url |
| 2022-11-14 | 1727196 | SRRK | 10-Q | Url |
| 2022-08-08 | 1727196 | SRRK | 10-Q | Url |
| 2022-05-16 | 1727196 | SRRK | 10-Q | Url |
| 2022-03-07 | 1727196 | SRRK | 10-K | Url |
| 2021-11-09 | 1727196 | SRRK | 10-Q | Url |
| 2021-08-10 | 1727196 | SRRK | 10-Q | Url |
| 2021-05-13 | 1727196 | SRRK | 10-Q | Url |
| 2021-03-09 | 1727196 | SRRK | 10-K | Url |
| 2020-11-09 | 1727196 | SRRK | 10-Q | Url |
| 2020-08-07 | 1727196 | SRRK | 10-Q | Url |
| 2020-05-07 | 1727196 | SRRK | 10-Q | Url |
| 2020-03-12 | 1727196 | SRRK | 10-K | Url |
| 2019-11-12 | 1727196 | SRRK | 10-Q | Url |
| 2019-08-14 | 1727196 | SRRK | 10-Q | Url |
| 2019-05-15 | 1727196 | SRRK | 10-Q | Url |
| 2019-03-19 | 1727196 | SRRK | 10-K | Url |
| 2018-11-08 | 1727196 | SRRK | 10-Q | Url |
| 2018-08-08 | 1727196 | SRRK | 10-Q | Url |
| 2018-04-27 | 1727196 | SRRK | S-1 | Url |
Scholar Rock Holding Corporation(NASDAQ:SRRK) 
Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, a novel inhibitor of the activation of l...
Website: http://www.scholarrock.com
Founded: 2012
Full Time Employees: 93
Sector: Healthcare
Industry: Biotechnology
The information provided in this report about SRRK stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.